Hidden danger: muscle disease linked to deadly clots

NCT ID NCT03424460

First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study investigates why people with myotonic dystrophy type 1 are 10 times more likely to develop dangerous blood clots in the legs or lungs. Researchers will compare blood samples from 130 participants—including patients with the disease, those with a history of clots, and healthy volunteers—to look for clotting abnormalities. The goal is to understand the cause, which could lead to better prevention strategies.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this research could point toward ways to prevent life-threatening blood clots in people with myotonic dystrophy type 1.
What could go wrong
This is an observational study, not a treatment trial. It may not lead directly to new therapies, and the findings might not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MYOTONIC DYSTROPHY 1 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Service de Cardiologie - Hôpital Cochin

    Paris, Île-de-France Region, 75014, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.